Cariprazine treatment in patients with borderline personality disorder and psychotic symptoms

Introduction Psychotic symptoms are frequently observed in individuals with borderline personality disorder. Numerous case reports in the scientific literature support this finding. This symptoms can significantly impair the patients daily functioning and quality of life. Antipsychotic medications have demonstrated efficacy in managing both psychotic symptoms and emotional dysregulation in this population. Objectives This case report aims to explore the use of cariprazine in managing psychotic symptoms in patients with borderline personality disorder. Methods This case report describes a 28-year-old woman who sought mental health treatment for symptoms including emotional instability, lability, irritability, anxiety, and impulsivity. Her history includes childhood sexual abuse, which she identified as a significant source of distress. She also reported chronic auditory pseudo-hallucinations with derogatory content and visual pseudo-hallucinations of “small spiders.” She reported these experiences as distressing and disruptive to her daily life. The patient recognized the unreal nature of these hallucinations. Results After initiating treatment with cariprazine 2.5mg, the patient demonstrated significant clinical improvement, including a reduction in the severity and impact of psychotic symptoms and a decreased risk of self-harm. Due to this positive response, cariprazine was continued, and the patient experienced increased emotional stability without requiring further acute care. Conclusions Studies have suggested the efficacy of second-generation antipsychotics in treating patients with borderline personality disorder. Beyond the remission of psychotic symptoms, these medications can lead to improvements in both affective and behavioral functioning. Disclosure of Interest None Declared

Authors

Institutions

Publication Details

Journal
European Psychiatry
Published
2025-04-01
DOI
https://doi.org/10.1192/j.eurpsy.2025.1926
Primary Topic
Personality Disorders and Psychopathology
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Cariprazine treatment in patients with borderline personality disorder and psychotic symptoms

H. Vizcaíno Herrezuelo, C. Delgado Marmisa, P. Del Sol Calderón, P. Pérez
European Psychiatry
Personality Disorders and Psychopathology
article

Cariprazine treatment in patients with borderline personality disorder and psychotic symptoms

H. Vizcaíno Herrezuelo, C. Delgado Marmisa, P. Del Sol Calderón, P. Pérez
article en

Abstract

Introduction Psychotic symptoms are frequently observed in individuals with borderline personality disorder. Numerous case reports in the scientific literature support this finding. This symptoms can significantly impair the patients daily functioning and quality of life. Antipsychotic medications have demonstrated efficacy in managing both psychotic symptoms and emotional dysregulation in this population. Objectives This case report aims to explore the use of cariprazine in managing psychotic symptoms in patients with borderline personality disorder. Methods This case report describes a 28-year-old woman who sought mental health treatment for symptoms including emotional instability, lability, irritability, anxiety, and impulsivity. Her history includes childhood sexual abuse, which she identified as a significant source of distress. She also reported chronic auditory pseudo-hallucinations with derogatory content and visual pseudo-hallucinations of “small spiders.” She reported these experiences as distressing and disruptive to her daily life. The patient recognized the unreal nature of these hallucinations. Results After initiating treatment with cariprazine 2.5mg, the patient demonstrated significant clinical improvement, including a reduction in the severity and impact of psychotic symptoms and a decreased risk of self-harm. Due to this positive response, cariprazine was continued, and the patient experienced increased emotional stability without requiring further acute care. Conclusions Studies have suggested the efficacy of second-generation antipsychotics in treating patients with borderline personality disorder. Beyond the remission of psychotic symptoms, these medications can lead to improvements in both affective and behavioral functioning. Disclosure of Interest None Declared

European PsychiatryVol. 68(S1)
Hospital Universitario Puerta de Hierro Majadahonda (ES)
Openalex Percentile: Top 65%
Personality Disorders and Psychopathology
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.